| abstract |
The invention relates to a pharmaceutical composition which is suitable in particular for the treatment of inflammatory diseases of the urogenital tract, preferably of cystitis. The composition according to the invention comprises, in combination and in each case in pharmaceutically effective amounts, hyaluronic acid and/or salts thereof, preferably with an average molar mass (molecular weight) of less than 200 kDa, and at least one further glycosaminoglycan different therefrom, preferably at least one chondroitin sulphate. |